Hydrocodone polymorphs

Details for Australian Patent Application No. 2006223129 (hide)

Owner Noramco Inc.

Inventors Hagen, Eric J.; Park, Aeri

Agent Shelston IP

Pub. Number AU-A-2006223129

PCT Pub. Number WO2006/099351

Priority 60/660,645 11.03.05 US

Filing date 8 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 489/00 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/099351 Priority application(s): WO2006/099351

8 November 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Oct 2007 2006227692 3M Innovative Properties Company The nature of the amendment is as shown in the statement(s) filed 25 Sep 2007

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223131-RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

2006223128-Method of multiplexing over an errorprone wireless broadcast channel